申请人:CHIESI FARMACEUTICI S.p.A.
公开号:US20140364412A1
公开(公告)日:2014-12-11
Compounds of formula (I) described herein are p38 MAPK inhibitors and are useful as anti-inflammatory agents in the treatment of, inter alia, diseases of the respiratory tract
本文描述的化合物(I)的公式是p38 MAPK抑制剂,可用作抗炎药物,用于治疗呼吸道疾病等。